Page last updated: 2024-10-30

metaproterenol and Spinal Cord Injuries

metaproterenol has been researched along with Spinal Cord Injuries in 4 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Spinal Cord Injuries: Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).

Research Excerpts

ExcerptRelevanceReference
" In this study, we evaluated whether a beta-2 adrenergic agonist, metaproterenol, had an effect on muscle size and strength in a group of patients with muscular atrophy following spinal cord injury."5.08Increased muscle strength in paralyzed patients after spinal cord injury: effect of beta-2 adrenergic agonist. ( Banovac, K; Caruso, JF; Flipse, D; Gomez, M; Lowensteyn, I; Signorile, JF, 1995)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Signorile, JF1
Banovac, K1
Gomez, M1
Flipse, D1
Caruso, JF1
Lowensteyn, I1
Dicpinigaitis, PV2
Spungen, AM2
Bauman, WA3
Absgarten, A1
Almenoff, PL3
DeLuca, RV1
Grimm, DR1
Lesser, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Double-blind, Placebo-controlled Trial to Determine the Effects and Duration of Action of Tiotropium Bromide on Pulmonary Function in Persons With SCI[NCT02586649]Phase 210 participants (Actual)Interventional2014-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for metaproterenol and Spinal Cord Injuries

ArticleYear
Increased muscle strength in paralyzed patients after spinal cord injury: effect of beta-2 adrenergic agonist.
    Archives of physical medicine and rehabilitation, 1995, Volume: 76, Issue:1

    Topics: Adult; Biomechanical Phenomena; Double-Blind Method; Humans; Male; Metaproterenol; Muscles; Muscular

1995

Other Studies

3 other studies available for metaproterenol and Spinal Cord Injuries

ArticleYear
Bronchial hyperresponsiveness after cervical spinal cord injury.
    Chest, 1994, Volume: 105, Issue:4

    Topics: Administration, Inhalation; Adult; Bronchial Hyperreactivity; Bronchial Provocation Tests; Forced Ex

1994
Pulmonary obstruction in individuals with cervical spinal cord lesions unmasked by bronchodilator administration.
    Paraplegia, 1993, Volume: 31, Issue:6

    Topics: Adult; Airway Obstruction; Bronchodilator Agents; Humans; Male; Metaproterenol; Middle Aged; Regress

1993
Effects of a beta2-agonist on airway hyperreactivity in subjects with cervical spinal cord injury.
    Chest, 1999, Volume: 115, Issue:6

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Bronchial Hyperreactivity; Bronch

1999